Yasser Khder

Internist and Cardiologist by education, Dr Khder also holds a Master in Clinical Pharmacology, a Master in Evaluation of Actions of Public Health and Ph.D in Human Science from the Université Henri Poincaré, Nancy, France.

After having worked as a non-invasive cardiologist and a clinical research physician for 4 years in the Hospital and in the National Institute of Health and Medical Research (INSERM), Dr Khder moved to the Pharmaceutical Industry and led early stage and late stage projects in hypertension, heart failure, acute coronary syndromes, thromboembolic diseases, atherosclerosis, kidney protection and inflammatory diseases; his last role in Novartis was a Global Program Medical Director at Global Clinical Development, consecutively for MAA868 (abelacimab), MOR106 and LOU064 (remibrutinib). Dr Khder is the founder and Snr life science consultant at MYRA LSS.